SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001080709-22-000008
Filing Date
2022-03-10
Accepted
2022-03-10 16:39:12
Documents
17
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A arna-20211231.htm   iXBRL 10-K/A 964232
2 EX-23.1 arna-20220310xexx231.htm EX-23.1 2993
3 EX-31.3 arna-20211231xexx313.htm EX-31.3 3794
4 EX-31.4 arna-20211231xexx314.htm EX-31.4 3824
8 arna-20211231_g1.jpg GRAPHIC 75793
  Complete submission text file 0001080709-22-000008.txt   1501704

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arna-20211231.xsd EX-101.SCH 2552
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arna-20211231_lab.xml EX-101.LAB 41006
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arna-20211231_pre.xml EX-101.PRE 21675
11 EXTRACTED XBRL INSTANCE DOCUMENT arna-20211231_htm.xml XML 19287
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-31161 | Film No.: 22729592
SIC: 2834 Pharmaceutical Preparations